Prominent bladder cancer risk factors in Iran

Asian Pacific Journal of Cancer Prevention

Volumn 11, Issue 3, 2010, Pages 601-606

  Shakhssalim, Nasser ^a   Hosseini, Seyed Yousef ^a   Basiri, Abbas ^a   Eshrati, Babak ^b   Mazaheri, Maria ^c   Soleimanirahbar, Ata ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^d UNRC   (Iran)

Author keywords

Case control study; Diet; Iran; Lifestyle; Opium; Risk factors; TCC bladder

Indexed keywords

EID: 78650689903     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bermejo JL, Sundquist J, Hemminki K (2009). Sex-specific familial risks of urinary bladder cancer and associated neoplasms in Sweden. Int J Cancer, 124, 2166-71.
2. Chen CH, Shun CT, Huang KH, et al (2008). Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and endstage renal disease. Urology, 71, 1155-60.
3. Chen C.Y., Liao Y.M., Tsai W.M., Kuo H.C(2007). Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease. J Formos Med Assoc, 106, 992-8.
4. Chyou PH, Nomura AM, Stemmermann GN (1993). A prospective study of diet, smoking, and lower urinary tract cancer. Ann Epidemiol, 3, 211-6.
5. Cohen SM, Shirai T, Steineck G(2000). Epidemiology and etiology of premalignant and malignant urothelial changes. Scand J Urol Nephrol Suppl, 10, 5-15.
6. Colombel M, Soloway M, Akaza H, Böhle A, Palou J (2008). Epidemiology, staging, grading, and risk stratification of bladder cancer. Eur Urol Suppl, 7, 618-26.
7. Daneshmand S, Becker TM (2009). Epidemiology and etiology of urothelial bladder cancer In: Raghavan D, Ross ME, editors.
8. Drugs U.N.O.o., Crime, Ctr V.I., Austria(2008). United Nations Office on Drugs and Crime: Annual Report 2008-Covering Activities in 2007.
9. Ferlay J, Bray F, Pisani P, Parkin D (2004). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC Cancer Base No. 5. version 2.0. IARC press, Lyon.
10. Fortuny J, Kogevinas M, Zens MS. et al (2007). Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study. BMC Urol, 7,13.
11. Genkinger JM, De Vivo I, Stampfer MJ, Giovannucci E, Michaud DS (2007). Nonsteroidal anti-inflammatory drug use and risk of bladder cancer in the health professionals follow-up study. Int J Cancer, 120, 2221-5.
12. Hosseini SY. Safarinejad MR, Amini E, Hooshyar H (2008). Opium consumption and risk of bladder cancer: A casecontrol analysis. Urol Oncol, ?, ?-?.
13. Huncharek M, Kupelnick B (2005). Personal use of hair dyes and the risk of bladder cancer: results of a meta-analysis. Public Health Rep, 120, 31-8.
14. Jhamb M, Lin J, Ballow R, et al (2007). Urinary tract diseases and bladder cancer risk: a case-control study. Cancer Causes Control, 18, 839-45.
15. Jiang X, Castelao JE, Groshen S, et al (2009). Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer, 100, 834-9.
16. Kantor AF, Hartge P, Hoover RN. et al (1984). Urinary tract infection and risk of bladder cancer. Am J Epidemiol, 119, 510-5.
17. Kelsh MA, Alexander DD, Kalmes RM, Buffler PA (2008). Personal use of hair dyes and risk of bladder cancer: a metaanalysis of epidemiologic data. Cancer Causes Control, 19, 549-58.
18. Kiemeney LA, Schoenberg M (1996). Familial transitional cell carcinoma. J Urol, 156, 867-72.
19. La Vecchia C, Negri E (1996). Nutrition and bladder cancer. Cancer Causes Control, 7, 95-100.
20. Larsson SC, Andersson SO, Johansson JE, Wolk A (2008). Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men. Eur J Cancer, 44, 2655-60.
21. Larsson SC, Orsini N, Brismar K, Wolk A (2006). Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia, 49, 2819-23.
22. Mousavi M (2005-2006). Iranian Annual National Cancer Registration Report. Tehran: Ministry of Health and Medical Education. 337 p.
23. Mueller CM, Caporaso N, Greene MH (2008). Familial and genetic risk of transitional cell carcinoma of the urinary tract. Urol Oncol, 26, 451-64.
24. Pannek J (2002). Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology, 59, 240-4.
25. Parsonnet J (1995). Bacterial infection as a cause of cancer. Environ Health Perspect, 103 Suppl 8, 263-8.
26. Pelucchi C, Bosetti C, Negri E, Malvezzi M, La Vecchia C (2006). Mechanisms of disease: The epidemiology of bladder cancer. Nat Clin Pract Urol, 3, 327-40.
27. Risdahl JM, Khanna KV, Peterson PK, Molitor TW (1998). Opiates and infection. J Neuroimmunol, 83, 4-18.
28. Sadeghi A, Behmard S, Vesselinovitch SD (1979). Opium: a potential urinary bladder carcinogen in man. Cancer, 43, 2315-21.